PT Hetzer Medical Indonesia Tbk (IDX:MEDS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
53.00
+2.00 (3.92%)
Aug 27, 2025, 3:49 PM WIB

IDX:MEDS Income Statement

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
3,3686,39122,72337,73775,79087,790
Upgrade
Revenue Growth (YoY)
-85.84%-71.88%-39.79%-50.21%-13.67%630.26%
Upgrade
Cost of Revenue
4,4315,86612,08616,71221,81229,182
Upgrade
Gross Profit
-1,063525.310,63721,02553,97858,607
Upgrade
Selling, General & Admin
8,5039,19913,24016,47219,9149,968
Upgrade
Operating Expenses
8,5039,19913,24016,47219,9149,968
Upgrade
Operating Income
-9,566-8,674-2,6034,55334,06448,639
Upgrade
Interest Expense
-476.28-482.4-663.42-759.2-180.42-10.1
Upgrade
Interest & Investment Income
0.630.822.8524.42233.1623.01
Upgrade
Other Non Operating Income (Expenses)
928.54881.55-323.87-3,22210.9537.31
Upgrade
Pretax Income
-9,114-8,274-3,587596.3234,12848,690
Upgrade
Income Tax Expense
263.36259.95-17.01359.257,49610,727
Upgrade
Net Income
-9,377-8,534-3,570237.0626,63137,962
Upgrade
Net Income to Common
-9,377-8,534-3,570237.0626,63137,962
Upgrade
Net Income Growth
----99.11%-29.85%12208.88%
Upgrade
Shares Outstanding (Basic)
1,5631,5631,5631,3731,2501,250
Upgrade
Shares Outstanding (Diluted)
1,5631,5631,5631,3731,2501,250
Upgrade
Shares Change (YoY)
--13.78%9.86%-17.63%
Upgrade
EPS (Basic)
-6.00-5.46-2.290.1721.3130.37
Upgrade
EPS (Diluted)
-6.00-5.46-2.290.1721.3130.37
Upgrade
EPS Growth
----99.19%-29.85%10363.81%
Upgrade
Free Cash Flow
-262.661,954-2,932-30,995-13,52441,305
Upgrade
Free Cash Flow Per Share
-0.171.25-1.88-22.57-10.8233.04
Upgrade
Gross Margin
-31.56%8.22%46.81%55.71%71.22%66.76%
Upgrade
Operating Margin
-284.06%-135.72%-11.46%12.07%44.95%55.40%
Upgrade
Profit Margin
-278.43%-133.52%-15.71%0.63%35.14%43.24%
Upgrade
Free Cash Flow Margin
-7.80%30.58%-12.90%-82.13%-17.84%47.05%
Upgrade
EBITDA
-5,550-4,472985.217,25435,59149,202
Upgrade
EBITDA Margin
-164.78%-69.97%4.34%19.22%46.96%56.05%
Upgrade
D&A For EBITDA
4,0174,2023,5882,7011,527562.22
Upgrade
EBIT
-9,566-8,674-2,6034,55334,06448,639
Upgrade
EBIT Margin
-284.06%-135.72%-11.46%12.07%44.95%55.40%
Upgrade
Effective Tax Rate
---60.25%21.96%22.03%
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.